OncoMatch/Clinical Trials/NCT06356714
Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status
Is NCT06356714 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for colorectal cancer.
Treatment: Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens — Evaluate the efficacy and safety of Nocardia rubra cell wall skeleton in combination with prior second- or third-line regimens for the treatment of potentially hazardous colorectal cancer SD(Stable Disease) status in the real world.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Colorectal Cancer
Performance status
ECOG 0–1(Restricted strenuous activity)
Prior therapy
Must have received: — second- or third-line therapy for advanced or metastatic colorectal cancer
Prior second- or third-line therapy for advanced or metastatic colorectal cancer
Lab requirements
Blood counts
absolute neutrophil count ≥ 1.5 x 10^9/L; hemoglobin ≥ 9.0 g/dl; platelet count ≥ 100 x 10^9/L
Kidney function
serum creatinine ≤ 1.5 x ULN
Liver function
total bilirubin ≤ 1.5 x ULN; gammaglutaminase and alkaline phosphatase ≤ 3 x ULN (≤ 5 x ULN for patients with hepatic/liver metastases)
absolute neutrophil count ≥ 1.5 x 10^9 /L; hemoglobin ≥ 9.0 g/dl; platelet count ≥ 100 x 10^9 /L; total bilirubin ≤ 1.5 x ULN; gammaglutaminase and alkaline phosphatase ≤ 3 x ULN (≤ 5 x ULN for patients with hepatic/liver metastases); serum creatinine ≤ 1.5 x ULN
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT06356714 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received .
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages